Company registration number 08134937 (England and Wales)
THINK THERAPY 1ST LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MAY 2025
31 May 2025
PAGES FOR FILING WITH REGISTRAR
THINK THERAPY 1ST LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
THINK THERAPY 1ST LIMITED
BALANCE SHEET
AS AT
31 MAY 2025
31 May 2025
- 1 -
2025
2024
as restated
Notes
£
£
£
£
Fixed assets
Intangible assets
4
14,400
21,600
Tangible assets
5
2,535
2,100
16,935
23,700
Current assets
Debtors
6
123,056
121,730
Cash at bank and in hand
1,130,125
543,853
1,253,181
665,583
Creditors: amounts falling due within one year
7
(1,045,380)
(546,919)
Net current assets
207,801
118,664
Total assets less current liabilities
224,736
142,364
Creditors: amounts falling due after more than one year
8
(15,042)
(49,205)
Provisions for liabilities
(188)
(460)
Net assets
209,506
92,699
Capital and reserves
Called up share capital
235
235
Profit and loss reserves
209,271
92,464
Total equity
209,506
92,699
THINK THERAPY 1ST LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MAY 2025
31 May 2025
- 2 -

For the financial year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 18 September 2025 and are signed on its behalf by:
..............................................
Mr M Willis, Esq.
Director
Company registration number 08134937 (England and Wales)
THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
- 3 -
1
Accounting policies
Company information

Think Therapy 1st Limited is a private company limited by shares incorporated in England and Wales. The registered office is 820 The Crescent, Colchester Business Park, Colchester, Essex, CO4 9YQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
- 5 years straight line
THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 4 -
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
- 20% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 5 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 6 -
1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 7 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
25
11
4
Intangible fixed assets
Other
£
Cost
At 1 June 2024 and 31 May 2025
36,000
Amortisation and impairment
At 1 June 2024
14,400
Amortisation charged for the year
7,200
At 31 May 2025
21,600
Carrying amount
At 31 May 2025
14,400
At 31 May 2024
21,600
THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 8 -
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 June 2024
4,686
Additions
968
At 31 May 2025
5,654
Depreciation and impairment
At 1 June 2024
2,586
Depreciation charged in the year
533
At 31 May 2025
3,119
Carrying amount
At 31 May 2025
2,535
At 31 May 2024
2,100
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
72,953
78,230
Corporation tax recoverable
5,717
-
0
Other debtors
44,386
43,500
123,056
121,730
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
34,090
31,891
Trade creditors
28,835
55,688
Amounts owed to group undertakings
100
100
Corporation tax
-
0
21,110
Other taxation and social security
28,348
-
0
Other creditors
954,007
438,130
1,045,380
546,919

Included within loans is a Bounce back Loan backed by Government guarantee. 2025 £10,319 (2024 £10,246)

 

Also included within loans is a Funding Circle Loan, which has a 70% government backed partial guarantee. The company has not provided any security against this loan. 2025 £23,770 (2024 £21,645)

THINK THERAPY 1ST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 9 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
15,042
49,205

Included within loans is a Bounce back Loan backed by Government guarantee. 2025 £113 (2024 £10,506)

 

Also included within loans is a Funding Circle Loan, which has a 70% government backed partial guarantee. The company has not provided any security against this loan. 2025 £14,929 (2024 £38,699)

9
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
23,264
-
10
Prior period adjustment
Reconciliation of changes in equity
1 June
31 May
2023
2024
£
£
Adjustments to prior year
Directors' compensation overstated
43,500
43,500
Equity as previously reported
3,819
49,199
Equity as adjusted
47,319
92,699
Analysis of the effect upon equity
Profit and loss reserves
43,500
43,500
2025-05-312024-06-01falsefalsefalse23 October 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMr M Willis, Esq.Mrs A Taylor-Willis081349372024-06-012025-05-31081349372025-05-31081349372024-05-3108134937core:IntangibleAssetsOtherThanGoodwill2025-05-3108134937core:IntangibleAssetsOtherThanGoodwill2024-05-3108134937core:OtherPropertyPlantEquipment2025-05-3108134937core:OtherPropertyPlantEquipment2024-05-3108134937core:CurrentFinancialInstrumentscore:WithinOneYear2025-05-3108134937core:CurrentFinancialInstrumentscore:WithinOneYear2024-05-3108134937core:CurrentFinancialInstruments2025-05-3108134937core:CurrentFinancialInstruments2024-05-3108134937core:Non-currentFinancialInstruments2025-05-3108134937core:Non-currentFinancialInstruments2024-05-3108134937core:ShareCapital2025-05-3108134937core:ShareCapital2024-05-3108134937core:RetainedEarningsAccumulatedLosses2025-05-3108134937core:RetainedEarningsAccumulatedLosses2024-05-3108134937bus:Director12024-06-012025-05-3108134937core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3108134937core:PatentsTrademarksLicencesConcessionsSimilar2024-06-012025-05-3108134937core:FurnitureFittings2024-06-012025-05-31081349372023-06-012024-05-3108134937core:IntangibleAssetsOtherThanGoodwill2024-05-3108134937core:OtherPropertyPlantEquipment2024-05-3108134937core:OtherPropertyPlantEquipment2024-06-012025-05-3108134937core:WithinOneYear2025-05-3108134937core:WithinOneYear2024-05-3108134937bus:PrivateLimitedCompanyLtd2024-06-012025-05-3108134937bus:SmallCompaniesRegimeForAccounts2024-06-012025-05-3108134937bus:FRS1022024-06-012025-05-3108134937bus:AuditExemptWithAccountantsReport2024-06-012025-05-3108134937bus:Director22024-06-012025-05-3108134937bus:FullAccounts2024-06-012025-05-31xbrli:purexbrli:sharesiso4217:GBP